15d
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
Origami Therapeutics, a biotech company developing small molecule protein degraders and conformation correctors to treat neurodegenerative diseases, today announced a global collaboration and option ...
Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results